Arvind Kumar Devansh Bhangadia HUF's Insider Trades & SAST Disclosures
Arvind Kumar Devansh Bhangadia HUF's most recent trade in Novelix Pharmaceuticals Ltd. was a Disposal of 120,000 Equity Shares done at an average price of Rs. 10 . Disclosure was reported to the exchange on Sept. 17, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Arvind Kumar Devansh Bhangadia HUF's has made SAST transactions in Novelix Pharmaceuticals Ltd. recently where a Disposal of 5,070,733 shares done . Disclosure was reported to the exchange on Sept. 16, 2024.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trimurthi | Arvind Kumar Devansh Bhangadia HUF & PACs | Promoter | Disposal | 16 Oct 2024 | 5,070,733 | 350,000 (3.52%) | 50.96% | - | 16 Sep 2024 16 Sep 2024 |
SAST (29(2)) | - | Off Market | |
| Trimurthi | Arvind Kumar Devansh Bhangadia (HUF) | Promoter | Disposal | 17 Sep 2024 | 120,000 | 0 (0%) | 1.21% | 10 | 1,200,000 | 16 Sep 2024 16 Sep 2024 |
Insider Trading | Equity Shares | Off Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.